ACTG 333--HARD CAPSULE AND SOFT CAPSULE SAQUINAVIR VS INDINAVIR

ACTG 333--硬胶囊和软胶囊沙奎那韦与印地那韦

• 批准号: 6245289
• 负责人: Robert Turner Schooley
• 金额: $ 2.65万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-02-14 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6245289
• 关键词: AIDS therapy; HIV infections; antiAIDS agent; antiviral agents; clinical research; clinical trials; drug administration rate /duration; drug screening /evaluation; human immunodeficiency virus; human subject; human therapy evaluation; microcapsule; microorganism disease chemotherapy; protease inhibitor; pyridine; quinoline

The activiral effect of switching from saquinavir to the new formulation of saquinavir vs. indinavir after more than one year of saquinovir use.

从沙奎那韦转用新制剂的激活作用 使用沙奎诺韦一年多后，沙奎那韦与茚地那韦的比较。